Cargando…

Alternation of the gut microbiota in metabolically healthy obesity: An integrated multiomics analysis

BACKGROUND: Although the gut microbiota may be involved in obesity onset and progression, the exact association of the gut microbiota in metabolically healthy obesity (MHO) remains largely unknown. METHODS: An integrated paired-sample metagenomic analysis was conducted to investigate the gut microbi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Han, Tang, Nana, Ye, Qiang, Yu, Xin, Yang, Ruoyun, Cheng, Hong, Zhang, Guoxin, Zhou, Xiaoying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663839/
https://www.ncbi.nlm.nih.gov/pubmed/36389176
http://dx.doi.org/10.3389/fcimb.2022.1012028
_version_ 1784830969887326208
author Chen, Han
Tang, Nana
Ye, Qiang
Yu, Xin
Yang, Ruoyun
Cheng, Hong
Zhang, Guoxin
Zhou, Xiaoying
author_facet Chen, Han
Tang, Nana
Ye, Qiang
Yu, Xin
Yang, Ruoyun
Cheng, Hong
Zhang, Guoxin
Zhou, Xiaoying
author_sort Chen, Han
collection PubMed
description BACKGROUND: Although the gut microbiota may be involved in obesity onset and progression, the exact association of the gut microbiota in metabolically healthy obesity (MHO) remains largely unknown. METHODS: An integrated paired-sample metagenomic analysis was conducted to investigate the gut microbial network and biomarkers of microbial species from the MHO and healthy non-obese subjects in the GMrepo database. Further explorations were performed in the MHO mice model using a multiomics analysis to detect changes in the composition and function of the intestinal microbiome and associated metabolites. RESULTS: In the human study, 314 matched metagenomic data were qualified for the final analysis. We identified seven significantly changed species possibly involved in MHO pathogenesis (MHO-enriched: Bacteroides vulgatus, Megamonas sp; MHO-depleted: Butyrivibrio crossotus, Faecalibacterium prausnitzii, Bacteroides cellulosilyticus; Eubacterium siraeum; Bacteroides massiliensis). In the murine study, we found 79 significantly-changed species which may have possible associations with the MHO phenotype. The depletion of Bacteroides cellulosilyticus was commonly recognized in the human and murine MHO phenotype. Consistent with the metagenomic data, liquid chromatography-mass spectrometry (LC/MS) revealed significantly changed gut metabolites, which may promote MHO pathogenesis by altering the amino acids and lipid metabolic pathways. In the microbe-metabolites interaction analysis, we identified certain fatty acids (Dodecanedioic acid, Arachidic Acid, Mevalonic acid, etc.) that were significantly correlated with the MHO-enriched or depleted species. CONCLUSION: This study provides insights into identifying specific microbes and metabolites that may involve in the development of obesity without metabolic disorders. Future modalities for MHO intervention may be further validated by targeting these bacteria and metabolites.
format Online
Article
Text
id pubmed-9663839
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96638392022-11-15 Alternation of the gut microbiota in metabolically healthy obesity: An integrated multiomics analysis Chen, Han Tang, Nana Ye, Qiang Yu, Xin Yang, Ruoyun Cheng, Hong Zhang, Guoxin Zhou, Xiaoying Front Cell Infect Microbiol Cellular and Infection Microbiology BACKGROUND: Although the gut microbiota may be involved in obesity onset and progression, the exact association of the gut microbiota in metabolically healthy obesity (MHO) remains largely unknown. METHODS: An integrated paired-sample metagenomic analysis was conducted to investigate the gut microbial network and biomarkers of microbial species from the MHO and healthy non-obese subjects in the GMrepo database. Further explorations were performed in the MHO mice model using a multiomics analysis to detect changes in the composition and function of the intestinal microbiome and associated metabolites. RESULTS: In the human study, 314 matched metagenomic data were qualified for the final analysis. We identified seven significantly changed species possibly involved in MHO pathogenesis (MHO-enriched: Bacteroides vulgatus, Megamonas sp; MHO-depleted: Butyrivibrio crossotus, Faecalibacterium prausnitzii, Bacteroides cellulosilyticus; Eubacterium siraeum; Bacteroides massiliensis). In the murine study, we found 79 significantly-changed species which may have possible associations with the MHO phenotype. The depletion of Bacteroides cellulosilyticus was commonly recognized in the human and murine MHO phenotype. Consistent with the metagenomic data, liquid chromatography-mass spectrometry (LC/MS) revealed significantly changed gut metabolites, which may promote MHO pathogenesis by altering the amino acids and lipid metabolic pathways. In the microbe-metabolites interaction analysis, we identified certain fatty acids (Dodecanedioic acid, Arachidic Acid, Mevalonic acid, etc.) that were significantly correlated with the MHO-enriched or depleted species. CONCLUSION: This study provides insights into identifying specific microbes and metabolites that may involve in the development of obesity without metabolic disorders. Future modalities for MHO intervention may be further validated by targeting these bacteria and metabolites. Frontiers Media S.A. 2022-11-01 /pmc/articles/PMC9663839/ /pubmed/36389176 http://dx.doi.org/10.3389/fcimb.2022.1012028 Text en Copyright © 2022 Chen, Tang, Ye, Yu, Yang, Cheng, Zhang and Zhou https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Chen, Han
Tang, Nana
Ye, Qiang
Yu, Xin
Yang, Ruoyun
Cheng, Hong
Zhang, Guoxin
Zhou, Xiaoying
Alternation of the gut microbiota in metabolically healthy obesity: An integrated multiomics analysis
title Alternation of the gut microbiota in metabolically healthy obesity: An integrated multiomics analysis
title_full Alternation of the gut microbiota in metabolically healthy obesity: An integrated multiomics analysis
title_fullStr Alternation of the gut microbiota in metabolically healthy obesity: An integrated multiomics analysis
title_full_unstemmed Alternation of the gut microbiota in metabolically healthy obesity: An integrated multiomics analysis
title_short Alternation of the gut microbiota in metabolically healthy obesity: An integrated multiomics analysis
title_sort alternation of the gut microbiota in metabolically healthy obesity: an integrated multiomics analysis
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663839/
https://www.ncbi.nlm.nih.gov/pubmed/36389176
http://dx.doi.org/10.3389/fcimb.2022.1012028
work_keys_str_mv AT chenhan alternationofthegutmicrobiotainmetabolicallyhealthyobesityanintegratedmultiomicsanalysis
AT tangnana alternationofthegutmicrobiotainmetabolicallyhealthyobesityanintegratedmultiomicsanalysis
AT yeqiang alternationofthegutmicrobiotainmetabolicallyhealthyobesityanintegratedmultiomicsanalysis
AT yuxin alternationofthegutmicrobiotainmetabolicallyhealthyobesityanintegratedmultiomicsanalysis
AT yangruoyun alternationofthegutmicrobiotainmetabolicallyhealthyobesityanintegratedmultiomicsanalysis
AT chenghong alternationofthegutmicrobiotainmetabolicallyhealthyobesityanintegratedmultiomicsanalysis
AT zhangguoxin alternationofthegutmicrobiotainmetabolicallyhealthyobesityanintegratedmultiomicsanalysis
AT zhouxiaoying alternationofthegutmicrobiotainmetabolicallyhealthyobesityanintegratedmultiomicsanalysis